Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pregnancy outcomes in women with type 1 diabetes using insulin degludec

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Glycemic Effects and Predictors of Increased Time-in-Range After Initiating MiniMed 670G: A 12-Month Observational Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A randomized clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. State of insulin pump use in the capital region of Denmark

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  • E Hommel
  • B Olsen
  • T Battelino
  • I Conget
  • I Schütz-Fuhrmann
  • R Hoogma
  • U Schierloh
  • N Sulli
  • H Gough
  • J Castañeda
  • S de Portu
  • J Bolinder
  • SWITCH Study Group
Vis graf over relationer

To investigate the impact of continuous glucose monitoring (CGM) on health-related quality of life (HRQOL), treatment satisfaction (TS) medical resource use, and indirect costs in the SWITCH study. SWITCH was a multicentre, randomized, crossover study. Patients with type 1 diabetes (n = 153) using continuous subcutaneous insulin infusion (CSII) were randomized to a 12 month sensor-On/Off or sensor-Off/On sequence (6 months each treatment), with a 4-month washout between periods. HRQOL in children and TS in adults were measured using validated questionnaires. Medical resource utilization data were collected. In adults, TS was significantly higher in the sensor-On arm, and there were significant improvements in ratings for treatment convenience and flexibility. There were no clinically significant differences in children's HRQOL or parents' proxy ratings. The incidence of severe hypoglycaemia, unscheduled visits, or diabetes-related hospitalizations did not differ significantly between the two arms. Adult patients made fewer telephone consultations during the sensor-On arm; children's caregivers made similar numbers of telephone consultations during both arms, and calls were on average only 3 min longer during the sensor-On arm. Regarding indirect costs, children with >70 % sensor usage missed fewer school days, compared with the sensor-Off arm (P = 0.0046) but there was no significant difference in the adults days of work off. The addition of CGM to CSII resulted in better metabolic control without imposing an additional burden on the patient or increased medical resource use, and offered the potential for cost offsets.

OriginalsprogEngelsk
TidsskriftActa Diabetologica
Vol/bind51
Udgave nummer5
Sider (fra-til)845-51
Antal sider7
ISSN0940-5429
DOI
StatusUdgivet - okt. 2014

ID: 45102515